Throughout 2016, the management liability marketplace as a whole showed a competitive rate environment across most product sectors. Moving into 2017 this rate environment will likely continue, though recent claim trends lend a level of uncertainty as to how long these conditions will last. Below you will find product sector market updates and relevant claims trends seen both nationally and within the Gallagher Management Liability Practice.
551 - 560 of 1909 items
Seyfarth Synopsis: Landmark Occupational Safety and Health Review Commission decision helps employers determine what steps need to be taken to protect employees from the hazards of heat at the workplace.
This Weekly Market Update reviews the top 3 market headlines: China Gets Downgraded, OPEC Extends Production Cuts and Declining Spreads in U.S. Treasury Notes
According to a Mayo Clinic study published April 4, 2017, nearly 90 percent of patients who came for a second opinion left with a different or adjusted final diagnosis. In addition, patient safety researchers at Johns Hopkins have found that diagnostic errors account for the majority of medical malpractice lawsuits, the most severe patient harm and have the highest indemnity.
Live and Interactive Webcasts for Supervisors. Free training held the second Tuesday of every month!
Canada Legislative Update - Ontario Proposes a New Pharmacare Program for Children & Youth Aged 24 and Under
Ontario’s 2017 budget includes a proposal for a new program (OHIP+: Children & Youth Pharmacare) to tackle the impact of increasing drug costs on individuals and plan sponsors.
Take a look at our 2016 Client Success Stories and how Gallagher was able to find a resolution to multiple issues in Claims Advocacy Practice.
Inside this newsletter: Nonprofit Affinity Groups: Q&A, Benefits Commentary, Benefits & HR Solutions Case Study Forum: Gatherings and Collaboration
This Weekly Market Update reviews the top 3 market headlines: Investors reminded volatility still exists, ECB treads lightly and industrial production increases.
This article discusses the state and evolution of director compensation plans among publicly traded companies. Findings are based on a recent study of director compensation plans among Russell 3000 companies. (Journal of Compensation & Benefits, 05/2017)